SMI-4a

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameSMI-4a

Drug Alias Namedual mTOR/Pim protein kinase inhibitors (Vortex Biotech)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitorsProto-oncogene serine/threonine-protein kinase Pim-1 inhibitorsSerine/threonine-protein kinase pim-3 inhibitors +[4]

TargetsSerine/threonine-protein kinase pim-2Proto-oncogene serine/threonine-protein kinase Pim-1Serine/threonine-protein kinase pim-3 +[4]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVortex Biotechnology Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVortex Biotechnology Corp

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A